Biggest News Aggregation in the World
๐Ÿ“ฐ Medication Guide News

Page 29 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Inside Christina Aguilera's Beauty Regimen

How Christina Aguilera preps before she goes onstage, onto the red carpet, about her everyday life, and more. For full Prescribing Information including BOXED WARNING and Medication Guide, visit XeominAesthetic.com. Please see full Important Consumer Safety Information at the end of this article.
Christina Aguilera Merz North America Inc Merz Pharma Gmbh Co Important Safety Information Full Prescribing Information Medication Guide

AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)

A total of 24 accepted abstracts, including six oral and digital oral presentations, reinforce AbbVies commitment to research that helps advance standards of...
United States Silvio Danese Ann Gastroenterol Gastroenterol Hepatol Abbvie Ltd Peuropean Society Of Gastrointestinal Endoscopy

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Moderna, Inc.: Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA , was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Melanom

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trialCAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / February 22, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering
United States United Kingdom Lavina Talukdar Erich Rubin Julie Cunningham Dennis Riedl

Merck to Present New Data for Sotatercept and MK-0616 at ACC.23/WCC, Demonstrating Significant Progr

RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of clinical data from its broad and advancing cardiovascular pipeline and portfolio at the upcoming American College of Cardiologyโ€™s 72nd Annual Scientific Session toget...
United States Julie Cunningham Peter Dannenbaum Damini Chokshi Eliav Barr World Heart Federation Congress

Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Takeda (TSE:4502/NYSE:TAK) today announced late-breaking data from the Phase 3 GRAPHITE study presented at the 2023 Tandem Meetings, demonstrating vedolizumab achieved a statistically significant and clinically meaningful improvement in lower gastrointestinal (GI) aGvHD-free survival by Day 180 after allo-HSCT with no relevant differences in safety profile versus placebo.1
United States Bin Chen John Cunningham Jun Saito Cancer Center International Blood Marrow Transplant Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science